BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Ergenç M, Uprak TK. YouTube as a source of information on Helicobacter pylori: Content and quality analysis. Helicobacter 2023;:e12971. [PMID: 36942858 DOI: 10.1111/hel.12971] [Reference Citation Analysis]
2 Chen Y, You N, Shen C, Wu J, Zhang J. Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease in diabetic population. Front Nutr 2023;10:1076579. [PMID: 36819677 DOI: 10.3389/fnut.2023.1076579] [Reference Citation Analysis]
3 Kim SE. Changes in Metabolic Parameters by Helicobacter pylori Eradication According to Sex Differences. Gut Liver 2023;17:1-2. [PMID: 36636882 DOI: 10.5009/gnl220541] [Reference Citation Analysis]
4 徐 真. Preliminary Study of Helicobacter Pylori Infection in the Endoscopy Center of a Grade-A Tertiary Hospital. ACM 2023;13:294-301. [DOI: 10.12677/acm.2023.131045] [Reference Citation Analysis]
5 Lee TH, Jeong HY, An DY, Kim H, Cho JY, Hwang DY, Lee HJ, Ham KS, Moon JH. Bamboo Salt and Triple Therapy Synergistically Inhibit Helicobacter pylori-Induced Gastritis In Vivo: A Preliminary Study. Int J Mol Sci 2022;23. [PMID: 36430475 DOI: 10.3390/ijms232213997] [Reference Citation Analysis]
6 Takeuchi H, Okamoto A. Helicobacter pylori Infection and Chronic Immune Thrombocytopenia. JCM 2022;11:4822. [DOI: 10.3390/jcm11164822] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Nabavi-Rad A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, Smith SM, Zali MR. The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes 2022;14:2108655. [PMID: 35951774 DOI: 10.1080/19490976.2022.2108655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Naoum G, Markantonis SL, Fanerou E, Siagkas G, Petropoulos F, Zafiris E, Kousovista R, Karalis V. On the Association between Gastrointestinal Symptoms and Extragastric Manifestations. Gastroenterol Res Pract 2022;2022:8379579. [PMID: 35761833 DOI: 10.1155/2022/8379579] [Reference Citation Analysis]
9 Yu JH, Zhao Y, Wang XF, Xu YC. Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations. Diagnostics (Basel) 2022;12. [PMID: 35626369 DOI: 10.3390/diagnostics12051214] [Reference Citation Analysis]
10 Durazzo M, Ferro A. Cardiovascular prevention: beyond the classical risk factors. Panminerva Med 2022;64:132-3. [PMID: 35330557 DOI: 10.23736/S0031-0808.21.04502-X] [Reference Citation Analysis]
11 Adriani A. Helicobacter pylori as potential agent in the pathogenesis of dementia. Minerva Med 2021;112:817. [PMID: 35168307 DOI: 10.23736/S0026-4806.21.07772-7] [Reference Citation Analysis]
12 Jun YK, Kim JW, Kim BG, Lee KL, Jung YJ, Kim W, Park HS, Lee DH, Koh S. Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis. PLoS ONE 2022;17:e0261448. [DOI: 10.1371/journal.pone.0261448] [Reference Citation Analysis]
13 Guo Y, Xu C, Zhang L, Chen Z, Xia X. Helicobacter pylori Infection Acts as an Independent Risk Factor for Intracranial Atherosclerosis in Women Less Than 60 Years Old. Front Cardiovasc Med 2022;8. [DOI: 10.3389/fcvm.2021.819315] [Reference Citation Analysis]
14 Kugler TE, Taradin GG, Pellicano R. The role of <i>Helicobacter pylori</i> in metabolic and cardiovascular diseases. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-86-95] [Reference Citation Analysis]
15 Kountouras J, Papaefthymiou A, Polyzos SA, Deretzi G, Vardaka E, Soteriades ES, Tzitiridou-Chatzopoulou M, Gkolfakis P, Karafyllidou K, Doulberis M. Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. Microorganisms 2021;9:2351. [PMID: 34835476 DOI: 10.3390/microorganisms9112351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Durazzo M, Adriani A, Fagoonee S, Saracco GM, Pellicano R. Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms 2021;9:2033. [PMID: 34683354 DOI: 10.3390/microorganisms9102033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gerçeker E, Cerrah S, Baykan A. Helicobacter pylori ve inflamatuvar bağırsak hastalığı arasındaki ilişki. Akademik Gastroenteroloji Dergisi 2021. [DOI: 10.17941/agd.975765] [Reference Citation Analysis]
18 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
19 Biernat MM, Wróbel T. Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. Int J Mol Sci 2021;22:7372. [PMID: 34298992 DOI: 10.3390/ijms22147372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
20 Attaran B, Salehi N, Ghadiri B, Esmaeili M, Kalateh S, Tashakoripour M, Eshagh Hosseini M, Mohammadi M. The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes. Gut Pathog 2021;13:43. [PMID: 34183046 DOI: 10.1186/s13099-021-00438-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? Front Endocrinol (Lausanne) 2021;12:639856. [PMID: 34220702 DOI: 10.3389/fendo.2021.639856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
22 Li R, Zhang P, Hu Z, Yi Y, Chen L, Zhang H. Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25949. [PMID: 34106668 DOI: 10.1097/MD.0000000000025949] [Reference Citation Analysis]
23 Yue CY, Peng Y, Gao CB, Zhang GS, Zhang F, Dong LL. Relationship between Helicobacter pylori infection and Hashimoto's thyroiditis: A prospective study. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 75-80 [DOI: 10.11569/wcjd.v29.i2.75] [Reference Citation Analysis]
24 Krzyżek P, Grande R, Migdał P, Paluch E, Gościniak G. Biofilm Formation as a Complex Result of Virulence and Adaptive Responses of Helicobacter pylori. Pathogens 2020;9:E1062. [PMID: 33353223 DOI: 10.3390/pathogens9121062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]